Sennoside A是一种从大黄根茎中分离得到的刺激性泻药,在肠道中引起通便作用。
Sennoside A, a kind of irritant laxative isolated from rhei rhizome, causes purgative actions in the intestine.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Hiraoka A, et al. Chem Pharm Bull, 1989, 37(10), 2744-2746.
分子式 C42H38O20 |
分子量 862.74 |
CAS号 81-27-6 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO |
Water <1 mg/mL |
Ethanol <1 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT00571896 | Constipation | Drug: Senna+ docusate|Drug: placebo | Hartford Hospital | Phase 2|Phase 3 | 2008-01-01 | 2012-01-03 |
NCT02239510 | Chronic Idiopathic Constipation | Drug: Senna|Drug: Linzess | TriHealth Inc. | 2014-09-01 | 2016-10-28 | |
NCT02618564 | Colonoscopy Preparation Outcome | Drug: Sennosides | Queen's University | 2015-12-01 | 2017-02-14 | |
NCT02008864 | End Stage Renal Disease|Pruritus | Drug: Senna|Drug: Placebo | Shiraz University of Medical Sciences | 2011-08-01 | 2015-03-30 | |
NCT00990951 | Constipation | Drug: Senna alexandrina and associations | Marjan Industria e Comercio ltda | Phase 3 | 2010-06-01 | 2014-07-07 |
NCT01531140 | Colonoscopy Preparation | Drug: polyethylene glycol +Bisacodyl|Drug: Polyethylene glycol|Drug: Sennosides | Medical University of Warsaw|Institute of Child Health | Phase 4 | 2010-11-01 | 2012-02-09 |
NCT01140295 | Colonoscopy Preparation | Drug: polyethylene glycol, senna | Children's Hospital of Philadelphia | Phase 4 | 2010-09-01 | 2013-04-10 |
NCT01189409 | Constipation|Cancer | Drug: PEG then Senna|Drug: Senna then PEG | British Columbia Cancer Agency | Phase 4 | 2010-06-01 | 2015-07-23 |
NCT00390598 | Colonoscopy | Drug: PEG (solution given 4 L)|Drug: senna glycoside 36 mg and PEG (solution given 2 L) | Ume氓 University | Phase 2|Phase 3 | 2005-09-01 | 2011-03-23 |
NCT00931853 | Constipation | Drug: SENNA+CASSIA(Naturetti) | Sanofi | Phase 3 | 2010-09-01 | 2012-10-16 |
NCT00994851 | Constipation | Drug: SENNA+CASSIA|Drug: placebo | Sanofi | Phase 3 | 2009-09-01 | 2013-03-28 |
NCT01057446 | Colonoscopy | Maltepe University|Marmara University | 2010-02-04 | |||
NCT00902031 | Constipation|Palliative Care | Drug: Docusate Sodium, Sennoside|Drug: Sennoside + Placebo | University of Alberta|College of Family Physicians of Canada (Janus Research Grant)|Covenant Health|Capital Care | 2006-04-01 | 2011-04-19 | |
NCT01695850 | Functional Constipation|Gastrointestinal Disorders | Drug: MZRW|Drug: Senna|Drug: placebo | Hong Kong Baptist University|Queen Elizabeth Hospital, Hong Kong|Prince of Wales Hospital, Shatin, Hong Kong | Phase 2 | 2013-06-01 | 2016-08-15 |
NCT00662363 | Constipation | Drug: Lubiprostone|Drug: Senna | Rehabilitation Institute of Chicago|Takeda Pharmaceuticals North America, Inc. | 2008-04-01 | 2013-02-27 | |
NCT00460837 | Colorectal Cancer | Drug: bowel preparation: senna & gastrofin versus picolax (standard) | London North West Healthcare NHS Trust | Phase 4 | 2007-11-01 | 2010-07-23 |
NCT00275184 | Small Bowel Disease|Gastrointestinal Hemorrhage|Refractory Anemia | Drug: Senna|Drug: Citramag powder|Drug: Metoclopramide | London North West Healthcare NHS Trust | Phase 3 | 2006-01-01 | 2007-09-21 |
NCT01773096 | Constipation | Drug: Methylnaltrexone|Drug: Senna, docusate sodium, bisacodyl, magnesium hydroxide, Miralax | Shriners Hospitals for Children | Phase 4 | 2013-05-01 | 2015-05-15 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们